Clinical trials
Completed Observational Lupus Erythematosus, Systemic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
102 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 1 |
| 2007 | 7 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 6 |
| 2011 | 1 |
| 2012 | 6 |
| 2013 | 7 |
| 2014 | 4 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 7 |
| 2018 | 7 |
| 2019 | 3 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 102 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 6 |
| AstraZeneca | 6 |
| GlaxoSmithKline | 6 |
| University Hospital, Grenoble | 4 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 3 |
| Northwell Health | 3 |
| Assiut University | 2 |
| Duke University | 2 |
| Fondation Ophtalmologique Adolphe de Rothschild | 2 |
| Janssen Research & Development, LLC | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 102 |
| Arthritis, Rheumatoid | 15 |
| Lupus Nephritis | 8 |
| Sjogren's Syndrome | 8 |
| Arthritis | 6 |
| Autoimmune Diseases | 6 |
| Crohn Disease | 6 |
| Scleroderma, Systemic | 6 |
| Spondylitis, Ankylosing | 6 |
| Arthritis, Psoriatic | 5 |
Trials
Showing 1 to 25 of 102. Each trial links to its page on Pharma Observatory.
2 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.